Samsung Biologics (207940): The Worldโs Biggest Antibody Factory Is Buying a Peptide Company
Updated 2 October 2026 — the first-stage issue price now exists, and our pricing date was wrong. The shares went […]
Bio
Korean biotech and pharma โ Samsung Biologics, LigaChem Bio, SK Biopharmaceuticals, and the next wave of K-Bio innovation.
Celltrion vs Samsung Biologics: Which Samsung Is Actually the Competitor?
English coverage of Korean biologics keeps pairing two names: Celltrion and Samsung. Headlines describe a “duel” and a race for
Celltrion (068270): It Promised to Cancel 4% of Itself, Delivered โ and the Share Count Went Up
In March 2026 a Korean biotech told its shareholders, in a regulatory filing that has no English counterpart, that it
LigaChem Bio Stock: Korea’s ADC Out-Licensing Machine (2026 Deep Dive)
Updated 3 October 2026 — the machine in the headline has stopped, and the money now runs the other way.
Samsung Biologics Valuation: CDMO Super-capacity and Biosecure Act Tailwind
๐ As of 3 July 2026 โ a point-in-time view. Financials corrected 30 Aug 2026. โ๏ธ Corrected 30 Aug 2026